魚躍醫療(002223.SZ)收購六六視覺95.95%股份完成交割
格隆匯1月3日丨魚躍醫療(002223.SZ)公佈,公司於2019年10月30日召開第四屆董事會第二十三次臨時會議審議通過關於《收購蘇州六六視覺科技股份有限公司95.95%股份》的議案,同意公司以自有資金3742.23225萬元收購蘇州六六視覺科技股份有限公司(“六六視覺”)95.95%的股份並授權管理層與六六視覺原股東蘇州工業園區陽中機械廠有限公司(“陽中機械”)、西安恆瑞工程流體設備有限公司(“西安恆瑞”)、茹臍華、楊霽威,共計4方(以下合稱“交易對方”、“轉讓方”)簽署《關於蘇州六六視覺科技股份有限公司之股份轉讓協議》。
截至公告披露日,此次交易的《股份轉讓協議》已簽署並生效,交易首期轉讓款已匯入與交易對方協議約定的賬户,《股份轉讓協議》及相關公告中約定的事項並未發生改變。
截至公告披露日,根據公司收到六六視覺提供的最新股東名冊,此次交易標的股份已完成過户,公司持有六六視覺95.95%的股份,六六視覺成為公司控股子公司,六六視覺股份變更已在工商登記備案,此次收購的交割事宜已完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.